Full List Of Stories
US close: Stocks lower amid Middle East tensions
Wall Street stocks closed sharply lower on Monday as investors looked past some solid retail sales numbers amid ongoing tensions in the Middle East.
Broker tips: Atome, Ceres Power
Analysts at Canaccord Genuity initiated coverage on Atome with a 'speculative buy' rating and 130. 0p target price on Monday, stating the company's choice to focus on finished ammonia fertiliser manufacture was "advantaged".
Director dealings: Abrdn CEO makes share sale
Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Audioboom swings to FY loss as revenues fall
Podcasting group Audioboom headed south after reporting a fall in full-year revenues and swinging to an underlying loss as a result of a "soft advertising market", constrained by macroeconomic headwinds.
Canaccord Genuity initiates coverage on Atome at 'speculative buy'
Analysts at Canaccord Genuity initiated coverage on Atome with a 'speculative buy' rating and 130. 0p target price on Monday, stating the company's choice to focus on finished ammonia fertiliser manufacture was "advantaged".
US open: Stocks higher following retail sales
Wall Street stocks were in the green early on Monday as retail sales boosted sentiment and market participants prepared for the beginning of another corporate earnings season.
US pre-open: Futures higher following last week's sell-off
Wall Street futures were in the green ahead of the bell on Monday as market participants strapped in for the beginning of corporate earnings season.
Renold FY results seen 'materially ahead' of market expectations
Industrial chains manufacturer Renold said on Monday that its full-year results would now be "materially ahead" of current market expectations as "strong" first-half momentum continued throughout H2.
Checkit secures three contract wins, launches new product
Software solutions firm Checkit said on Monday that it has secured new contract wins from two existing customers worth a minimum of £417,000 in total lifetime revenues over their three-year terms.
Getech secures three separate contract wins
Subsurface resources locator Getech said on Monday that it had secured three separate contract wins related to the exploration of natural hydrogen.
Faron Pharmaceuticals CFO stands down
Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".
Ixico inks supply agreement with LMI
Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical trials.